Caboxamycin, a new antibiotic of the benzoxazole family produced by the deep-sea strain Streptomyces sp. NTK 937. (Q33406492)

26 July 2017

title

Caboxamycin, a new antibiotic of the benzoxazole family produced by the deep-sea strain Streptomyces sp. NTK 937. (English)

1 reference

26 July 2017

0 references

0 references

1 reference

1 reference

Amanda L Jones

7

0 references

Roderich D. Süssmuth

object named as

Roderich D Süssmuth

14

0 references

Michael Goodfellow

10

object named as

Michael Goodfellow

1 reference

26 July 2017

Claudia Hohmann

1

1 reference

26 July 2017

Kathrin Schneider

2

1 reference

26 July 2017

Christina Bruntner

3

1 reference

26 July 2017

Elisabeth Irran

4

1 reference

26 July 2017

Graeme Nicholson

5

1 reference

26 July 2017

Alan T Bull

6

1 reference

26 July 2017

Roselyn Brown

8

1 reference

26 July 2017

James E M Stach

9

1 reference

26 July 2017

Winfried Beil

11

1 reference

26 July 2017

Marco Krämer

12

1 reference

26 July 2017

Johannes F Imhoff

13

1 reference

26 July 2017

Hans-Peter Fiedler

15

1 reference

26 July 2017

publication date

23 January 2009

1 reference

full work available at URL

26 July 2017

https://www.nature.com/articles/ja200824.pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2008.24?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

1 reference

26 July 2017

volume

62

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

99-104

1 reference

https://api.unpaywall.org/v2/10.1038/ja.2008.24?email=unpaywall_01@example.com

26 July 2017

1 reference

19 March 2024

access restriction status

open access

1 reference

inferred from online access status

cites work

Marine actinomycete diversity and natural product discovery.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

Marine actinomycetes as a source of novel secondary metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

Developing a new resource for drug discovery: marine actinomycete bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

Discovery of novel metabolites from marine actinomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

Marine actinobacteria: new opportunities for natural product search and discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

Nataxazole, a new benzoxazole derivative with antitumor activity produced by Streptomyces sp. Tü 6176.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

Statistical approaches for estimating actinobacterial diversity in marine sediments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

Synthesis and evaluation of anticancer benzoxazoles and benzimidazoles related to UK-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

Synthesis and anticancer evaluation of bis(benzimidazoles), bis(benzoxazoles), and benzothiazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

Keynote review: phosphodiesterase-4 as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

Neutrotolerant acidophilic Streptomyces species isolated from acidic soils in China: Streptomyces guanduensis sp. nov., Streptomyces paucisporeus sp. nov., Streptomyces rubidus sp. nov. and Streptomyces yanglinensis sp. nov.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

A new device for rapid evaluation of biofilm formation potential by bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

7 January 2021

AJI9561, a new cytotoxic benzoxazole derivative produced by Streptomyces sp.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

7 January 2021

UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. II. Structural elucidation

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

7 January 2021

UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. III. Antibacterial action of demethyl UK-1

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

7 January 2021

UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. IV. Antifungal action of methyl UK-1

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

7 January 2021

Critical structural motif for the catalytic inhibition of human topoisomerase II by UK-1 and analogs

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

7 January 2021

The discovery, fermentation, isolation, and structure of antibiotic A33853 and its tetraacetyl derivative

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

7 January 2021

New pentaenes from the sponge-derived marine fungus Penicillium rugulosum: structure determination and biosynthetic studies

1 reference

https://api.crossref.org/works/10.1038%2FJA.2008.24

7 January 2021

Identifiers

DOI

10.1038/JA.2008.24

1 reference

Dimensions Publication ID

26 July 2017

1009194099

0 references

1 reference